Time filter

Source Type

The V5s uses a 20MP front camera to take selfie technology to the next level with exquisite clarity and vivid, natural colors. The new selfie function also supports bokeh effects to deliver crystal-clear portrait focus and artistic background blurring. The V5s is powered by an octa-core CPU, with 4GB RAM and 64GB ROM (expandable to 256GB with a microSD card). This powerful hardware configuration, together with the updated Funtouch OS 3.0 operating system (based on Android 6.0), guarantees a smoother selfie and photography experience. The optimized Selfie Softlight creates lighting effects that are comparable to professional photography studios. The function captures radiant complexions even in low-light conditions. In addition, Vivo's Face Beauty 6.0 function allows users to beautify selfies with one click. Dedicated to cutting-edge smart phone photography technology, V5s also introduces the Group Selfie feature to capture every smile in a group shot without squeezing in or missing anyone. Meanwhile, the 52MP Ultra HD photo feature shoots multiple frames in quick succession and creates remarkable 52MP photos with more detail and less noise. Other features of the V5s include: "By launching the brand new V5s, Vivo heralds a new era of photography in the mobile phone industry," noted Feng. "It continues to offer users gorgeous selfies and an enjoyable user experience by upgrading our photography technologies as well as introducing new features." For more information about the Vivo V5s, please visit: www.vivo.com The V5s will be available in matte black, crown gold and rose gold. It will land in India, Indonesia, Malaysia, Thailand, Vietnam and the Philippines in May. A young global smartphone brand focusing on introducing perfect sound quality and ultimate photography with cutting-edge technology, Vivo develops dynamic and stylish products for passionate young people. The company ranks among the top 5 smartphone brands worldwide according to IDC's Q4 2016 report. To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/vivos-new-flagship-smartphone-v5s-enables-perfect-selfies-in-low-light-environments-300449483.html


SHENZHEN, China, May 12, 2017 /PRNewswire/ -- Leading smartphone manufacturer Vivo will launch its latest flagship mobile smartphone, the V5s, a new member of the V series of devices today. The V5s continues Vivo's record of delivering phones that provide users with "Perfect Selfies" with an advanced 20MP front camera and optimized Selfie Softlight feature as well as 4GB RAM and 64GB ROM. "Our focus group shows that users tend to take selfies in their everyday life," explained Alex Feng, Global Vice President at Vivo. "The V5s is a ground-breaking smartphone that aids users' pursuit of the perfect selfie in low-light environments and fulfills their desire to beautify portraits with natural effects." The V5s uses a 20MP front camera to take selfie technology to the next level with exquisite clarity and vivid, natural colors. The new selfie function also supports bokeh effects to deliver crystal-clear portrait focus and artistic background blurring. The V5s is powered by an octa-core CPU, with 4GB RAM and 64GB ROM (expandable to 256GB with a microSD card). This powerful hardware configuration, together with the updated Funtouch OS 3.0 operating system (based on Android 6.0), guarantees a smoother selfie and photography experience. The optimized Selfie Softlight creates lighting effects that are comparable to professional photography studios. The function captures radiant complexions even in low-light conditions. In addition, Vivo's Face Beauty 6.0 function allows users to beautify selfies with one click. Dedicated to cutting-edge smart phone photography technology, V5s also introduces the Group Selfie feature to capture every smile in a group shot without squeezing in or missing anyone. Meanwhile, the 52MP Ultra HD photo feature shoots multiple frames in quick succession and creates remarkable 52MP photos with more detail and less noise. Other features of the V5s include: "By launching the brand new V5s, Vivo heralds a new era of photography in the mobile phone industry," noted Feng. "It continues to offer users gorgeous selfies and an enjoyable user experience by upgrading our photography technologies as well as introducing new features." For more information about the Vivo V5s, please visit: www.vivo.com The V5s will be available in matte black, crown gold and rose gold. It will land in India, Indonesia, Malaysia, Thailand, Vietnam and the Philippines in May. A young global smartphone brand focusing on introducing perfect sound quality and ultimate photography with cutting-edge technology, Vivo develops dynamic and stylish products for passionate young people. The company ranks among the top 5 smartphone brands worldwide according to IDC's Q4 2016 report.


SHENZHEN, China, May 4, 2017 /PRNewswire/ -- Leading smartphone manufacturer Vivo will launch its latest flagship mobile smartphone, the V5s, a new member of the V series of devices today. The V5s continues Vivo's record of delivering phones that provide users with "Perfect Selfies" with an advanced 20MP front camera and optimized Selfie Softlight feature as well as 4GB RAM and 64GB ROM. "Our focus group shows that users tend to take selfies in their everyday life," explained Alex Feng, Global Vice President at Vivo. "The V5s is a ground-breaking smartphone that aids users' pursuit of the perfect selfie in low-light environments and fulfills their desire to beautify portraits with natural effects." The V5s uses a 20MP front camera to take selfie technology to the next level with exquisite clarity and vivid, natural colors. The new selfie function also supports bokeh effects to deliver crystal-clear portrait focus and artistic background blurring. The V5s is powered by an octa-core CPU, with 4GB RAM and 64GB ROM (expandable to 256GB with a microSD card). This powerful hardware configuration, together with the updated Funtouch OS 3.0 operating system (based on Android 6.0), guarantees a smoother selfie and photography experience. The optimized Selfie Softlight creates lighting effects that are comparable to professional photography studios. The function captures radiant complexions even in low-light conditions. In addition, Vivo's Face Beauty 6.0 function allows users to beautify selfies with one click. Dedicated to cutting-edge smart phone photography technology, V5s also introduces the Group Selfie feature to capture every smile in a group shot without squeezing in or missing anyone. Meanwhile, the 52MP Ultra HD photo feature shoots multiple frames in quick succession and creates remarkable 52MP photos with more detail and less noise. Other features of the V5s include: "By launching the brand new V5s, Vivo heralds a new era of photography in the mobile phone industry," noted Feng. "It continues to offer users gorgeous selfies and an enjoyable user experience by upgrading our photography technologies as well as introducing new features." For more information about the Vivo V5s, please visit: www.vivo.com The V5s will be available in matte black, crown gold and rose gold. It will land in India, Indonesia, Malaysia, Thailand, Vietnam and the Philippines in May. A young global smartphone brand focusing on introducing perfect sound quality and ultimate photography with cutting-edge technology, Vivo develops dynamic and stylish products for passionate young people. The company ranks among the top 5 smartphone brands worldwide according to IDC's Q4 2016 report.


Grant
Agency: Department of Health and Human Services | Branch: | Program: SBIR | Phase: Phase II | Award Amount: 739.07K | Year: 2012

DESCRIPTION (provided by applicant): The overall objective of this SBIR proposal is to develop and commercialize a human 3D or mini- liver bioassay system suitable for real-time analysis of metabolic functions and long-term drug toxicity profiles. At present, liver functions are mostly studied using HepG2 cell line and primary hepatocytes cultured onto collagen or polymer matrices. However, these 2D monolayer models allow only partial or short-term toxicity analysis due to rapid loss of metabolic functions.Interestingly, spheroid formation in 3D matrix/scaffold cultures is shown to improve host cell functions. In Phase I studies, we successfully demonstrated the feasibility of a new human bioscaffold- 3D HuBiogel (high-density gel) for supporting long-termsurvival and maintenance of primary liver cells. Moreover, integration of rotary bioreactor system allowed efficient production/analysis of viable mini-liver spheroids. We now propose to complete the development of new 3D-liver bioassay platform that exhibits improved metabolic functions, and thus will enable precise drug toxicity testing in vitro. Phase II specific goals are: 1. Establish an efficient hepatic cells cultivation protocol by optimizing 3D HuBiogel scaffolds and rotary bioreactor or perfusionculture strategies; 2. Test functionality of 3D-liver culture model by evaluating key biochemical and metabolism endpoints; and 3. Validate the practical utility of mini-liver assay system via real- time analysis of CYP450 induction and chemical/drug toxicity responses. Comparative control studies will include 3D culture scaffolds of Type-I collagen or Matrigel as well as fresh human liver-slice cultures. High throughput adaptability of 3D-liver bioassay will also be examined for toxicogenomics via CYP-microarrays. Thus, biologic relevance of new marketable 3D-liver bioassay system will be confirmed for improved drug toxicity analysis/prediction in humans. We are confident this advanced in vitro hepatotoxicity model will positively impact basic, preclinicaland biomedical research arenas. Commercial Importance and Significance: No acceptable commercial liver toxicity assay currently exists which utilizes a human bio-scaffold culture system. VBI will develop a market-ready 3D-liver assay platform adaptable toHTS applications. Sale of 3D HuBiogel culture kits or in-house bioassay services would have significant world-wide market, as a research and diagnostic tool. PUBLIC HEALTH RELEVANCE: Current cell-based assay models for studying drug metabolism and toxicity are of limited utility because isolated liver cells die rapidly in their no-physiologic, 2-dimensional (2D) culture formats. In Phase I, we have shown that a novel human 3-dimensional (3D or high- density) biomatrix scaffold- HuBiogel supportslong-term cultivation, survival and functions of primary human liver cells. In Phase II, we will complete the development of new mini-liver bioassay platform by employing 3D HuBiogel scaffolds combined with rotary or perfusion culture techniques. High throughput utility of this robust 3D hepatotoxicity assay will greatly advance biochemical, metabolic and molecular analysis beyond 2D culture methods. Thus, our RandD effort provides a much needed in vitro tool for real-time analysis of chemical/drug metabolism and liver toxicity responses in humans. A successful outcome will offer new market-ready bioassay kits and services with world-wide demand in both basic and pharmaceutical research areas.


Grant
Agency: Department of Health and Human Services | Branch: | Program: STTR | Phase: Phase I | Award Amount: 192.31K | Year: 2014

DESCRIPTION (provided by applicant): In this Phase I STTR proposal, our RandD goal is the development and evaluation of a novel functionally-graded biohybrid vascular graft for small diameter (lt6 mm) coronary bypass applications. Tissue engineered vascular constructs developed to date have mostly utilized synthetic and animal- derived biomaterials and require pre-seeding of host cells before implantation to overcome the complications of prosthetic vascular grafts. However, these graft systems exhibit manylimitations including poor cellular adhesion, inadequate biomechanical and functional properties. The PI has recently demonstrated an in vitro regenerated human endothelium on functionally-layered polymeric scaffolds containing bioactive proteins. Moreover, VBI has developed a unique human biomatrix (HuBiogel) that allows viable tissue constructs by cultivating single or multiple cell types. HuBiogel milieu can also be controlled via enrichment with specific growth factors (VEGF). We now propose to combin


Grant
Agency: Department of Health and Human Services | Branch: | Program: SBIR | Phase: Phase I | Award Amount: 279.41K | Year: 2013

Not Available


Grant
Agency: Department of Health and Human Services | Branch: National Institutes of Health | Program: SBIR | Phase: Phase I | Award Amount: 219.81K | Year: 2015

Not Available


Grant
Agency: Department of Health and Human Services | Branch: National Institutes of Health | Program: SBIR | Phase: Phase II | Award Amount: 1.97M | Year: 2015

Not Available


Grant
Agency: Department of Health and Human Services | Branch: | Program: SBIR | Phase: Phase I | Award Amount: 156.98K | Year: 2014

DESCRIPTION (provided by applicant): This SBIR project is focused to develop, validate and commercialize an advanced high-throughput anti- tumor drug screening platform (HTS) which employs a new 3D HuBioGEM assay technology. Preclinical drug screening is commonly performed using biochemical and cell-based assay systems. In recent years, more relevant 3D spheroid models have been developed using microcarrier, pHEMA- coating, gel-layer and hanging-drop techniques. Although useful, these require difficult culture protocols, provide undesirable endpoints and/or are not efficient for automated applications. We have created a novel HuBioGEM culture system by formulating patented HuBiogel (human biomatrix) with unique paramagnetic particles (GEM). Employing 3D magnetic-biogel and 384-array culture strategies, we propose to develop a robust human microtumor assay platform for drug efficacy profiling. Phase I technical goals are: i) Establish 3D tumor production, culture and analysis protocols using HuBioGEM, NCI


Systems and methods estimate expected loss risk to computers and enterprises based on the data files present on computers and data file clusters within the enterprise.

Loading Vivo Inc collaborators
Loading Vivo Inc collaborators